Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Minority Interest (2022)

VYNE Therapeutics' Minority Interest history spans 1 years, with the latest figure at $211000.0 for Q4 2022.

  • For Q4 2022, Minority Interest changed N/A year-over-year to $211000.0; the TTM value through Dec 2022 reached $211000.0, changed N/A, while the annual FY2022 figure was $211000.0, N/A changed from the prior year.
  • Minority Interest reached $211000.0 in Q4 2022 per VYNE's latest filing.
  • In the past five years, Minority Interest ranged from a high of $211000.0 in Q4 2022 to a low of $211000.0 in Q4 2022.